ProMIS Neurosciences’ Neil Cashman to Speak at Protein Misfolding Drug Discovery Conference

by NASDAQ Market News October 13, 2020

NASDAQ Market News
Click here to email author

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020

Randomized Controlled Phase 3 Trial of Remestemcel-L for Reduced Mortality in COVID-19 Acute Respiratory Distress Syndrome Surpasses 50% Enrollment

Ads